Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | HTR2A | P28223 | 11/20 | 0.40 |
| ▸ | DRD3 | P35462 | 5/20 | 0.40 |
| ▸ | ACKR3 | P25106 | 5/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 6/20 | 0.32 |
| ▸ | DRD2 | P14416 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31478977 | 1.00 | KCNH2 (0.49) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31479313 | 1.00 | KCNH2 (0.49) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31478952 | 0.91 | MEN1 (0.42) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31479231 | 0.90 | MEN1 (0.49) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31479419 | 0.88 | MEN1 (0.49) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31479895 | 0.88 | KCNH2 (0.49) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31480019 | 0.79 | GPR119 (0.40) | — | |
| SCHEMBL31479610 | 0.79 | MEN1 (0.51) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31478741 | 0.79 | MEN1 (0.53) | KCNH2MEN1KMT2AHTR2ADRD3 | |
| SCHEMBL31479447 | 0.78 | HCRTR1 (0.34) | KMT2AHTR2AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025067111-A1 | MENIN-MLL INTERACTION INHIBITOR AND PREPARATION METHOD THEREFOR, AND APPLICATION | 苏州必扬医药科技有限公司 | 2025-04-03 | — | — | WO | disclosed |